KRM Ayurveda Limited KRMAYURVEDshare price and chart
KRM Ayurveda closed at ₹224.00 on 19 November 2026, up 2.82% on the day. The range since listing is ₹156.15 to ₹343.95.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on KRMAYURVED
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 19 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026What the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 13 Nov 2026), sales was ₹34.7 cr and profit was ₹8.1 cr.
- No borrowings at the FY26 balance sheet.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Who owns itEach line is that holder's share of all shares over the last 2 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Insider tradesPurchases and sales of the company's own shares by promoters, directors and senior staff.
Last 18 monthsRecent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsKey ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Pharmaceuticals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
Where the cash wentIn FY26 cash rose by ₹7 Cr, after ₹1 Cr spent on plant and equipment.
The full numbersSales and net profit by financial year or by quarter.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | · | +13.6 | -13.3 | +35.0 | +10.3 | -1.2 | +6.7 | +3.8 | +4.1 | -24.1 | -0.6 | · | +26.0% 10m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2026-04-17 | MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulk | SELL | 2,02,000 | ₹235.97 | ₹4.77 Cr |
| 2026-04-17 | AFFLUENCE GEMS PRIVATELIMITED · bulk | BUY | 2,00,000 | ₹236.00 | ₹4.72 Cr |
| 2026-03-23 | EXPERTPRO REALTY PRIVATE LIMITED · bulk | SELL | 2,11,000 | ₹190.00 | ₹4.01 Cr |
| 2026-02-03 | EXPERTPRO REALTY PRIVATE LIMITED · bulk | BUY | 1,12,000 | ₹168.05 | ₹1.88 Cr |
| 2026-02-03 | ALGOQUANT FINTECH LIMITED · bulk | SELL | 1,09,000 | ₹168.05 | ₹1.83 Cr |
| 2026-01-29 | EXPERTPRO REALTY PRIVATE LIMITED · bulk | BUY | 3,25,000 | ₹172.10 | ₹5.59 Cr |
| 2026-01-29 | ALGOQUANT FINTECH LIMITED · bulk | BUY | 2,50,000 | ₹172.10 | ₹4.30 Cr |
| 2026-01-29 | ANKITA VISHAL SHAH · bulk | BUY | 1,50,000 | ₹172.10 | ₹2.58 Cr |
- Board outcomeOutcome of Board Meeting13 Nov 2026
KRM Ayurveda Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting10 Aug 2026
KRM Ayurveda Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
- Press releasePress Release2 May 2026
The Company is going to Press Release/ Media Release on the Audited Standalone Financial Results of the Company for the half year ended and year ended March 31, 2026.
- Board outcomeOutcome of Board Meeting1 May 2026
KRM Ayurveda Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test KRMAYURVED. “Buy KRMAYURVED when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free